Pfizer RFP Optimizing HRRm Testing and Workflow Integration in mCSPC
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Friday 3rd, April 2026
External Deadline: Wednesday 8th, April 2026
Description
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.
For all quality improvement grants, Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program. An ISR grant request cannot be submitted for a study that has already commenced and was not originally supported by Pfizer.
Date RFP Issued: January 12, 2026
Geographic Scope: Canada
Clinical Area: Oncology – Genitourinary
Link to full RFP: Optimizing HRRm Testing and Workflow Integration in mCSPC
Application Due Date: April 8, 2026
Specific Area of Interest: This Request for Proposals (RFP) seeks to fund projects that incorporate robust, long-term sustainability plans. Priority will be given to proposals that clearly demonstrate how their programs can continue to operate in the absence of additional grant funding. Eligible projects may include initiatives that:
- – Optimize the HRRm testing process
- – Advance equitable and sustainable access
- – Strengthen integration within multidisciplinary teams
– Evaluate system performance and real-world outcomes
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Ying Ying (Elena) Huang, Grant Officer (yingying.huang@pfizer.com).